【Good News】Haibu Pharmaceutical&≈★27;s Lacosamide Oral Solut←≥σ∏ion (Brand Name: Vianz ♥₹u®) has been successfully€ approved!
Classification:
Company News
Release time:
2023-09-18

Beijing Haibu PharmaceuΩσtical Technology Co., Ltd. (re✔₩'ferred to as "Haibu Pharmaceγσ'utical") was established in 2005 and isα↓☆ a high-tech enterprise with "cheΩ≈♠mical drug research and develop∏Ωment" as its core capabil✔¶πity. It has a research and devel ♦ε♦opment center in Beijing, a γ€λ∞pilot verification center for raw♣£↑ materials and formulations, ☆<"and a GMP industrial produ☆£ction base. The company mainly engag®≤es in CRO services for raw mate☆ rials and formulations, jo←☆↓≤int licensing with MAH, related applica≥α₹★tions for raw materials, and comme≠↓®rcial supply of pharmaceuticε∞al intermediates. The R&'≤→D products cover multiple thera→π peutic areas including anti-tumor,→→ anti-depression, anλ₽'ti-epilepsy, anti-anxie★≥£↓ty, cardiovascular, dige×₩™stive system, respir↓☆atory system, etc.
Haibu Pharmaceutical has been >★awarded the title of "To≠©•÷p 20 Pharmaceutical R&D Companies i→←↑σn China" for several consecutive y→β≥ears and has been recog₩¶•₽nized as a "Specialize∏←d, Refined, Characteristic and Inn≈®δovative" enterprise in Beijing♣'±±, a "National High-tech ↓ Enterprise", a "Beijing Science and≈ ± Technology Research Deve♦"lopment Institution", and a "B"eijing Yizhuang Enterprise ∏✔₹Innovation Center", am✔€★ong others.



